MASIERO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 6.270
AS - Asia 4.955
EU - Europa 2.524
SA - Sud America 803
AF - Africa 771
Continente sconosciuto - Info sul continente non disponibili 176
OC - Oceania 80
Totale 15.579
Nazione #
US - Stati Uniti d'America 5.676
SG - Singapore 1.416
CN - Cina 881
IT - Italia 871
VN - Vietnam 683
HK - Hong Kong 512
BR - Brasile 473
BD - Bangladesh 362
CA - Canada 161
FR - Francia 159
DE - Germania 157
PL - Polonia 130
NL - Olanda 124
GB - Regno Unito 120
IN - India 120
FI - Finlandia 116
JP - Giappone 91
SE - Svezia 82
AR - Argentina 78
IQ - Iraq 77
RU - Federazione Russa 77
KR - Corea 75
TR - Turchia 66
MX - Messico 53
AT - Austria 52
SA - Arabia Saudita 51
ES - Italia 48
EC - Ecuador 47
GR - Grecia 46
PH - Filippine 45
UA - Ucraina 45
ZA - Sudafrica 42
JM - Giamaica 41
PK - Pakistan 41
ID - Indonesia 40
CO - Colombia 38
IE - Irlanda 38
AO - Angola 34
BJ - Benin 33
CL - Cile 33
MA - Marocco 33
VE - Venezuela 33
UZ - Uzbekistan 31
RO - Romania 30
CI - Costa d'Avorio 29
GT - Guatemala 29
PE - Perù 29
KE - Kenya 28
MY - Malesia 28
PY - Paraguay 28
AU - Australia 27
BE - Belgio 27
BG - Bulgaria 26
IR - Iran 26
ET - Etiopia 25
TH - Thailandia 25
TN - Tunisia 25
AE - Emirati Arabi Uniti 24
KH - Cambogia 24
LB - Libano 24
NP - Nepal 24
BB - Barbados 23
CH - Svizzera 23
CM - Camerun 23
HN - Honduras 23
TJ - Tagikistan 23
EG - Egitto 22
GH - Ghana 22
NI - Nicaragua 22
PS - Palestinian Territory 22
CR - Costa Rica 21
CU - Cuba 21
DZ - Algeria 21
GE - Georgia 21
IL - Israele 21
KZ - Kazakistan 21
LY - Libia 21
MD - Moldavia 21
MG - Madagascar 21
PR - Porto Rico 21
TT - Trinidad e Tobago 21
BY - Bielorussia 20
CZ - Repubblica Ceca 20
DO - Repubblica Dominicana 20
JO - Giordania 20
MK - Macedonia 20
AL - Albania 19
AZ - Azerbaigian 19
BA - Bosnia-Erzegovina 19
BS - Bahamas 19
HR - Croazia 19
MU - Mauritius 19
NG - Nigeria 19
SK - Slovacchia (Repubblica Slovacca) 19
SN - Senegal 19
BW - Botswana 18
LV - Lettonia 18
NE - Niger 18
SI - Slovenia 18
AM - Armenia 17
Totale 14.603
Città #
San Jose 919
Ashburn 866
Singapore 840
Hong Kong 448
Santa Clara 256
Los Angeles 214
Ho Chi Minh City 194
Fairfield 193
Hanoi 180
Beijing 179
Council Bluffs 179
Chandler 172
Woodbridge 122
New York 116
Milan 99
Lauterbourg 83
Houston 82
Boardman 80
Rome 79
Ann Arbor 78
Seattle 78
Cambridge 69
Wilmington 69
Bytom 68
Tokyo 65
Hefei 64
Helsinki 61
Dallas 59
Chicago 57
Orem 57
Padova 56
Buffalo 55
Seoul 55
Munich 48
São Paulo 46
Denver 45
Da Nang 43
Phoenix 39
Montreal 37
Toronto 35
Vienna 34
Dublin 32
Medford 32
Cotonou 31
Naples 31
Nuremberg 31
Princeton 31
Turku 31
Kingston 30
Abidjan 29
London 29
Atlanta 28
Baghdad 28
Brooklyn 28
Shanghai 28
Dong Ket 27
Padua 27
Tashkent 27
Luanda 26
Stockholm 26
Palermo 24
Rio de Janeiro 24
San Diego 24
Warsaw 24
Dushanbe 23
Gdansk 23
Nairobi 23
Phnom Penh 23
Frankfurt am Main 22
Addis Ababa 21
Athens 21
Bridgetown 21
Guatemala City 21
Redondo Beach 21
The Dalles 21
Haiphong 20
Managua 20
Antananarivo 19
Brasília 19
Havana 19
Istanbul 19
Johannesburg 19
Nassau 19
Accra 18
Amman 18
Amsterdam 18
Baku 18
Chennai 18
Dakar 18
Des Moines 18
Bologna 17
Falkenstein 17
Guangzhou 17
Mexico City 17
Noumea 17
Quito 17
San José 17
Boston 16
Lappeenranta 16
Lusaka 16
Totale 7.854
Nome #
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 372
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 360
Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation 331
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 322
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies 280
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 277
Definition of trAnscatheter heart Valve orIeNtation in biCuspId aortic valve: The DA VINCI pilot study 274
Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 255
Management and Outcome of Failed Percutaneous Edge-to-Edge Mitral Valve Plasty: Insight From an International Registry 255
Spontaneous coronary artery dissection in women with acute myocardial infarction: is there a new role for autoimmunity? 254
Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction 250
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 245
Impact of Pulmonary Hypertension on Outcomes after Transcatheter Tricuspid Valve Edge-to-Edge Repair 243
A2-P3 oblique clipping for the treatment of severe mitral regurgitation in the presence of mitral valve cleft and flail 241
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 239
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413) 235
Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 233
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 228
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome 222
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 220
[Percutaneous transcatheter treatment of pulmonary embolism: results of the SICI-GISE national survey promoted by the GISE-Young Committee] 217
“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413) 215
AUTOANTIBODIES TARGETING ENDOTHELIN TYPE-A AND ANGIOTENSIN TYPE-1 RECEPTORS ASSOCIATE WITH RISK OF MICROVASCULAR OBSTRUCTION AFTER STEMI 213
Transcatheter aortic valve-in-valve implantation for the treatment of a failed surgical bioprosthesis of small size 213
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 203
Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience 201
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 195
[Left main percutaneous coronary intervention using zotarolimus-eluting stent: data from the ROLEX registry] 194
Mechanical Circulatory Support with Impella: Principles, Evidence, and Daily Practice 193
When to Achieve Complete Revascularization in Infarct-Related Cardiogenic Shock 192
Evaluation of tricuspid valve regurgitation following transvenous rotational mechanical lead extraction 189
Impact of Updated Invasive Right Ventricular and Pulmonary Hemodynamics on Long-Term Outcomes in Patients With Mitral Valve Transcatheter Edge-to-Edge Repair 188
Breaking Down Cardiogenic Shock: An Analytical Reflection on the DanGer-SHOCK and ECLS-SHOCK Trials 187
Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation 184
10-Year Impact of Transcatheter Aortic Valve Replacement Leaflet Design (Intra- Versus Supra-Annular) in Mortality and Hemodynamic Performance 178
Computed Tomography Scan Predictors and Prognostic Impact of Combined Pulmonary Hypertension in Patients with Aortic Valve Stenosis undergoing TAVI 177
Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score 173
[PCSK9 inhibitor use in high cardiovascular risk patients: an interventionalist's overview on efficacy, current recommendations and factual prescription] 170
Efficacy and safety of potent platelet P2Y12 receptor inhibitors in elderly versus nonelderly patients with acute coronary syndrome: A systematic review and meta-analysis 167
Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease 161
Transcatheter edge‐to‐edge repair in severe mitral regurgitation following acute myocardial infarction – aetiology‐based analysis 160
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis 160
Management of myocarditis in clinical practice 156
Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction 155
Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy 152
[Right heart catheterization in Italian catheterization laboratories: results of the SICI-GISE national survey promoted by the GISE Young Committee] 149
The BVS concept. From the chemical structure to the vascular biology: the bases for a change in interventional cardiology 146
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome 144
Unmasking Myocardial Bridge–Related Ischemia by Quantitative Flow Ratio Functional Evaluation 144
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 143
Isolated tricuspid regurgitation: a new entity to face. Prevalence, prognosis and treatment of isolated tricuspid regurgitation 142
Percutaneous transcatheter treatment of hypertension and heart failure: Results of the SICI-GISE national survey promoted by the GISE Young Committee 140
Atrial Secondary Tricuspid Regurgitation 139
[Management of patients with myocardial ischemia/infarction with non-obstructive coronary artery disease in Italian catheterization laboratories: results of the SICI-GISE national survey promoted by the GISE Young Committee] 138
Transcatheter edge‐to‐edge repair in papillary muscle injury complicating acute myocardial infarction 135
Abstract 12535: Spontaneous Coronary Artery Dissection in Women: A New Role for Autoimmunity? 133
Angioplastica con pallone medicato: risultati nella malattia coronarica multivasale 133
Exploring Therapists’ Emotional Responses with Individuals Diagnosed with Antisocial Personality Disorder: A Scoping Review 132
Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry 129
Center Valve Preference and Outcomes of Transcatheter Aortic Valve Replacement: Insights From the AMTRAC Registry 128
Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry 128
Gender issues in Italian catheterization laboratories: The gender-cath study 126
Abstract 12646: Autoantibodies Targeting Endothelin Type-A Receptors Associate With no Reflow After ST-elevation Myocardial Infarction 125
[Bioresorbable vascular scaffolds: from science to clinical parctice] 125
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 125
La duplice terapia antiaggregante (DAPT) dopo sindrome coronarica acuta: short DAPT o de-escalation 125
Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality 123
Lo studio ABSORB III 122
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 120
Early readmission after mitral valve repair: God is in the details 120
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Atrial Functional Mitral Regurgitation from the GIOTTO Registry 118
Mechanical circulatory support in cardiogenic shock: a critical appraisal 116
Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry 113
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 110
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 109
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis 108
Abstract 12559: Functional Autoantibodies Against Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Predict Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 106
Impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair 97
Angioplastica coronarica guidata da tomografia a coerenza ottica vs guida angiografica: risultati dello studio clinico randomizzato ILUMIEN IV 94
Sex, Antithrombotics, and Outcomes After TAVR: Is There More Difference Within Sexes or Between Them? 92
Heart failure hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: Insights from EuroTR 86
Sex and cardiogenic shock: Still no time for answers but for evidences 82
Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment 81
Timing and treatment strategies according to SCAI classification in cardiogenic shock 77
Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices 76
The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI 74
Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women 72
Studio EBC MAIN: confronto randomizzato tra strategia provisional graduale e doppio stenting sistematico nel trattamento della biforcazione del tronco comune 72
Impact of age on outcomes after transcatheter tricuspid valve edge-to-edge repair: insights from EuroTR 72
Functional autoantibodies and coronary microvascular obstruction in STEMI: a translational link between immune mechanisms and prognostic outcomes 72
Insufficienza tricuspidale secondaria atriale: una valvulopatia sottostimata ma di crescente rilevanza clinica 66
[GISE/ANMCO/SIC Consensus document on the implementation of the new recommendations for the use of coronary functional testing and intravascular imaging in coronary angioplasty for chronic coronary syndromes] 58
Sex-based Differences in Complications Following Percutaneous Coronary Interventions 56
Invasive Hemodynamics and Risk Stratification in T-TEER: Moving Beyond ESC Thresholds: EuroTR Registry Insights 54
Impact of age on outcomes after transcatheter tricuspid valve edge-to-edge repair: insights from EuroTR 53
Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices: Insights From EuroTR 52
Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry 51
Bioresorbable Coronary Scaffold Technologies: What's New? 50
Sex‐Specific Considerations in Degenerative Aortic Stenosis for Female‐Tailored Transfemoral Aortic Valve Implantation Management 35
Multicenter Registry of Patients Treated With Impella Mechanical Circulatory Support Device in Italy: Sex Subanalysis 34
Totale 15.579
Categoria #
all - tutte 42.389
article - articoli 42.140
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022340 0 0 17 24 20 43 9 40 58 22 21 86
2022/2023409 54 24 14 62 48 41 5 25 25 17 28 66
2023/2024436 20 51 43 46 36 28 50 20 44 19 29 50
2024/20252.027 19 138 62 82 215 103 103 178 167 86 321 553
2025/202610.142 518 599 1.281 1.480 868 503 1.315 800 1.057 551 618 552
2026/20271.573 806 407 360 0 0 0 0 0 0 0 0 0
Totale 15.579